help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 11, 2007, doi:10.1164/rccm.200608-1114OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200608-1114OCv1
176/3/253    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Criner, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Criner, G. J.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 253-260, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200608-1114OC


Original Article

Effect of Lung Volume Reduction Surgery on Resting Pulmonary Hemodynamics in Severe Emphysema

Gerard J. Criner1, Steven M. Scharf2, Jeremy A. Falk1, John P. Gaughan1, Alice L. Sternberg3, Namrata B. Patel1, Henry E. Fessler3, Omar A. Minai4, Alfred P. Fishman5 and for the National Emphysema Treatment Trial Research Group*

1 Temple University, Philadelphia, Pennsylvania; 2 University of Maryland, Baltimore, Maryland; 3 Johns Hopkins University, Baltimore, Maryland; 4 Cleveland Clinic Foundation, Cleveland, Ohio; and 5 University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence and requests for reprints should be addressed to Gerard J. Criner, M.D., Pulmonary and Critical Care Medicine, Temple University School of Medicine, 3401 North Broad Street, Philadelphia, PA 19140. E-mail: crinerg{at}tuhs.temple.edu

Rationale: To determine the effect of medical treatment versus lung volume reduction surgery (LVRS) on pulmonary hemodynamics.

Methods: Three clinical centers of the National Emphysema Treatment Trial (NETT) screened patients for additional inclusion into a cardiovascular (CV) substudy. Demographics were determined, and lung function testing, six-minute-walk distance, and maximum cardiopulmonary exercise testing were done at baseline and 6 months after medical therapy or LVRS. CV substudy patients underwent right heart catheterization at rest prerandomization (baseline) and 6 months after treatment.

Measurements and Main Results: A total of 110 of the 163 patients evaluated for the CV substudy were randomized in NETT (53 were ineligible), 54 to medical treatment and 56 to LVRS. Fifty-five of these patients had both baseline and repeat right heart catheterization 6 months postrandomization. Baseline demographics and lung function data revealed CV substudy patients to be similar to the remaining 1,163 randomized NETT patients in terms of age, sex, FEV1, residual volume, diffusion capacity of carbon monoxide, PaO2, PaCO2, and six-minute-walk distance. CV substudy patients had moderate pulmonary hypertension at rest (Formula, 24.8 ± 4.9 mm Hg); baseline hemodynamic measurements were similar across groups. Changes from baseline pressures to 6 months post-treatment were similar across treatment groups, except for a smaller change in pulmonary capillary wedge pressure at end-expiration post-LVRS compared with medical treatment (–1.8 vs. 3.5 mm Hg, p = 0.04).

Conclusions: In comparison to medical therapy, LVRS was not associated with an increase in pulmonary artery pressures.

Key Words: emphysema • LVRS • lung volume reduction


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
The effect of lung volume reduction surgery on pulmonary hemodynamics is controversial and has only been reported from small, uncontrolled, single-center trials.

What This Study Adds to the Field
In comparison to medical therapy, lung volume reduction surgery was not associated with an increase in pulmonary artery pressures.

 



This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J., November 1, 2008; 32(5): 1371 - 1385.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. E. O'Donnell and K. A. Webb
The major limitation to exercise performance in COPD is dynamic hyperinflation
J Appl Physiol, August 1, 2008; 105(2): 753 - 755.
[Full Text] [PDF]


Home page
Eur Respir JHome page
E. M. Clini and N. Ambrosino
Nonpharmacological treatment and relief of symptoms in COPD
Eur. Respir. J., July 1, 2008; 32(1): 218 - 228.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz
Cardiac Disease in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. J. Lederer, E. K. T. Benn, R. G. Barr, J. S. Wilt, G. Reilly, J. R. Sonett, S. M. Arcasoy, and S. M. Kawut
Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 450 - 454.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. A. Falk, U. J. Martin, S. Scharf, and G. J. Criner
Lung Elastic Recoil Does Not Correlate With Pulmonary Hemodynamics in Severe Emphysema
Chest, November 1, 2007; 132(5): 1476 - 1484.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  ATS PAR News